Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR2 | O15552 | 18/20 | 0.62 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1677071 | 1.00 | FFAR2 (0.62) | FFAR2ADRB2MEN1LMNAKMT2A | |
| SCHEMBL1677147 | 1.00 | FFAR2 (0.62) | FFAR2ADRB2MEN1LMNAKMT2A | |
| SCHEMBL29639815 | 0.88 | FFAR2 (0.47) | FFAR2LMNA | |
| SCHEMBL10614514 | 0.82 | FFAR2 (0.61) | FFAR2ADRB2MEN1LMNAKMT2A | |
| SCHEMBL10614521 | 0.82 | FFAR2 (0.61) | FFAR2ADRB2MEN1LMNAKMT2A | |
| SCHEMBL1405698 | 0.82 | FFAR2 (0.65) | FFAR2MEN1LMNAKMT2A | |
| SCHEMBL1677207 | 0.82 | FFAR2 (0.65) | FFAR2MEN1LMNAKMT2A | |
| SCHEMBL1780649 | 0.82 | FFAR2 (0.65) | FFAR2MEN1LMNAKMT2A | |
| SCHEMBL3880453 | 0.82 | FFAR2 (0.65) | FFAR2MEN1LMNAKMT2A | |
| SCHEMBL68169 | 0.82 | FFAR2 (0.65) | FFAR2MEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160243015-A1 | SKIN LIGHTENING COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-08-25 | — | — | US | disclosed |
| US-8252564-B2 | Burkholderia multivorans strain and methods of using same | LG CHEM, LTD. (KR) | 2012-08-28 | — | — | US | disclosed |
| US-20110097768-A1 | Novel Burkholderia Multivorans LG 31-3, Amidase Produced From the Same, and Method for Resolution of Racemic Mixture Using the Same | LG CHEM, LTD. (KR) | 2011-04-28 | — | — | US | disclosed |
| WO-2007114668-A1 | NOVEL BURKHOLDERIA MULTIVORANS LG 31-3, AMIDASE PRODUCED FROM THE SAME, AND METHOD FOR RESOLUTION OF RACEMIC MIXTURE USING THE SAME | LG CHEM, LTD. (KR) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160243015-A1 | SKIN LIGHTENING COMPOSITION | TYR, MC1R, MITF | FFAR2 4424/4885ADRB2 1224/4885MEN1 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.